Laparoscopic Microwave Thermal Ablation for the Treatment of Hepatocellular Carcinoma in Chronic Hepatic Patients

Alessandro Tropea, Marco Barbara, Sergio Calamia, Laura Lomaglio, Pasquale Bonsignore, Fabrizio Di Francesco, Duilio Pagano, Salvatore Gruttadauria

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Laparoscopic microwave thermal ablation (LMWTA) is a well-established alternative treatment to liver resection for treatment of liver tumors. The aim of this study was to describe our experience in LMWTA for hepatocellular carcinoma (HCC) in chronic hepatic patients. Materials and Methods: A study group of 61 consecutive HCC patients treated with LMWTA from January, 2013 to May, 2020 were considered for this study. Patient characteristics, liver function test, operational characteristics, and complications were recorded. Results: Of the 61 patients who underwent LMWTA, median age was 64 (interquartile range [IQR]: 58-71) years, mean body mass index was 26.2 (IQR: 23.2-29.4); 44 patients (72%) presented with an hepatitis C virus etiology, 46 (75%) were Child-Pugh Class A, median model for end-stage liver disease (MELD) score was 8.0 (IQR: 7.0-9.4). Viral infection was confirmed to be the most important risk factor in determining progressive cirrhotic evolution with HCC expression. Conclusions: LMWTA is a safe alternative treatment to traditional surgery, and can be combined with surgery.

Original languageEnglish
Pages (from-to)1072-1075
Number of pages4
JournalJournal of Laparoendoscopic and Advanced Surgical Techniques - Part A
Volume30
Issue number10
DOIs
Publication statusPublished - Oct 2020

Fingerprint Dive into the research topics of 'Laparoscopic Microwave Thermal Ablation for the Treatment of Hepatocellular Carcinoma in Chronic Hepatic Patients'. Together they form a unique fingerprint.

Cite this